Altium Capital Management LP Natera, Inc. Transaction History

Altium Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $2.77 Million - $4.25 Million	75,000 New	75,000 $3.29 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $1.06 Million - $3.2 Million	-35,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $905,730 - $1.25 Million	-10,500 Reduced 23.08%	35,000 $3.27 Million
Q3 2021 Nov 17, 2021	BUY	$100.17 - $126.36 $4.56 Million - $5.75 Million	45,500 New	45,500 $5.07 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $3.33 Million - $4.2 Million	-33,230 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $2.86 Million - $3.98 Million	33,230 New	33,230 $3.77 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.